These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10742982)

  • 1. Multidrug-resistance transporters.
    Silverman JA
    Pharm Biotechnol; 1999; 12():353-86. PubMed ID: 10742982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake.
    Gutmann H; Fricker G; Török M; Michael S; Beglinger C; Drewe J
    Pharm Res; 1999 Mar; 16(3):402-7. PubMed ID: 10213371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions.
    Marquez B; Van Bambeke F
    Curr Drug Targets; 2011 May; 12(5):600-20. PubMed ID: 21039335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
    Zhou SF
    Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.
    Smith AJ; van Helvoort A; van Meer G; Szabo K; Welker E; Szakacs G; Varadi A; Sarkadi B; Borst P
    J Biol Chem; 2000 Aug; 275(31):23530-9. PubMed ID: 10918072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein.
    Enright EF; Govindarajan K; Darrer R; MacSharry J; Joyce SA; Gahan CGM
    Mol Pharm; 2018 Dec; 15(12):5711-5727. PubMed ID: 30388019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and function of the multidrug resistance genes in liver.
    Silverman JA; Thorgeirsson SS
    Prog Liver Dis; 1995; 13():101-23. PubMed ID: 9224499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
    Fromm MF
    Int J Clin Pharmacol Ther; 2000 Feb; 38(2):69-74. PubMed ID: 10706193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABC Transporter-Mediated Multidrug-Resistant Cancer.
    Amawi H; Sim HM; Tiwari AK; Ambudkar SV; Shukla S
    Adv Exp Med Biol; 2019; 1141():549-580. PubMed ID: 31571174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
    Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
    Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring interactions at ATP-dependent drug efflux pumps.
    Hendrikse NH
    Curr Pharm Des; 2000 Nov; 6(16):1653-68. PubMed ID: 10974159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
    Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
    Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
    Eisenblätter T; Hüwel S; Galla HJ
    Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
    Keppler D
    Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of efflux drug transporters in the intestine.
    Takano M; Yumoto R; Murakami T
    Pharmacol Ther; 2006 Jan; 109(1-2):137-61. PubMed ID: 16209890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
    Fardel O; Payen L; Courtois A; Vernhet L; Lecureur V
    Toxicology; 2001 Oct; 167(1):37-46. PubMed ID: 11557128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.